Inspire Medical gains on GLP-1 prospects [Seeking Alpha]
ResMed Inc. (RMD)
Last resmed inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.resmed.com/investor-relations/default.aspx
Company Research
Source: Seeking Alpha
"We are excited about GLP-1s. And what GLP-1s can do to our business is significant," CEO Tim Herbert said at the Morgan Stanley Healthcare Conference on Wednesday. Unlike its larger peers, ResMed ( RMD ) and Philips ( PHG ), Inspire ( INSP ) markets a minimally invasive medical implant to treat obstructive sleep apnea. The trio came under pressure in June after Eli Lilly ( LLY ), which dominates the obesity drug market with rival Novo Nordisk ( NVO ), said its GLP-1 tirzepatide met the main goals in a Phase 3 program for adults with obesity and OSA. "We have so many patients that just cannot qualify for Inspire therapy because they have a high BMI," Herbert explained. "We are working with physicians to make sure they understand the benefits of the GLP-1s, what that can do to help their patients lose weight and thereby qualify for Inspire." Recommended For You More Trending News Recommended For You More Trending News About INSP Stock Related Stocks Trending Analys
Show less
Read more
Impact Snapshot
Event Time:
RMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RMD alerts
High impacting ResMed Inc. news events
Weekly update
A roundup of the hottest topics
RMD
News
- Moderna was most shorted S&P 500 healthcare stock in August for second consecutive month [Seeking Alpha]Seeking Alpha
- Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]Yahoo! Finance
- Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]Yahoo! Finance
- ResMed (NYSE:RMD) stock performs better than its underlying earnings growth over last five years [Yahoo! Finance]Yahoo! Finance
- Reasons to Retain ResMed Stock in Your Portfolio for Now [Yahoo! Finance]Yahoo! Finance
RMD
Earnings
- 8/1/24 - Beat
RMD
Sec Filings
- 9/13/24 - Form 4
- 9/12/24 - Form 144
- 9/10/24 - Form 4
- RMD's page on the SEC website